IRadimed Corporation provided revenue guidance for the fourth quarter and full year 2022. For quarter the Company's prior revenue guidance remains unchanged as it expects to report revenue of $14.1 million to $14.8 million. The Company expects to report GAAP diluted earnings per share of $0.23 to $0.28 per share .

For full-year the company expects revenue of $52.5 million to $53.2 million.